Prescription medication · Neuromuscular Blocker
botulinum toxin A
Also sold as Botox. Botox can treat overactive bladder with symptoms like needing to go often, feeling a strong urge, and leaking urine.
Data updated 2026-05-15
- Rx
- Availability
botulinum toxin A (Botox) is a prescription Neuromuscular Blocker. Botox can treat overactive bladder with symptoms like needing to go often, feeling a strong urge, and leaking urine.
Botox is a drug that blocks nerve signals to muscles. It is used to treat a variety of conditions, including overactive bladder, chronic migraines, and muscle spasticity.
Verify with FDA → · CMS NADAC pricing →
What it does
Botox can treat overactive bladder with symptoms like needing to go often, feeling a strong urge, and leaking urine.
Common side effects
Urinary tract infection, Pain when urinating, Inability to fully empty the bladder
Key warnings
Botox can cause the toxin's effects to spread beyond the injection site.
The sections below are summarized in plain English from botulinum toxin A's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Botox works by blocking the release of a chemical called acetylcholine. This chemical tells muscles to contract. By blocking acetylcholine, Botox prevents muscles from contracting.
Serious Warnings
Botox can cause the toxin's effects to spread beyond the injection site. This can cause muscle weakness, trouble seeing, drooping eyelids, trouble swallowing or breathing, voice changes, difficulty speaking clearly, and loss of bladder control. Swallowing and breathing problems can be life-threatening, and there have been reports of death. Seek medical care right away if you have any of these symptoms.
Common Questions
What should I tell my doctor before using Botox?
Can I drive after getting Botox?
How long does Botox last?
What if I have an allergic reaction to Botox?
Can Botox interact with other medications?
What happens if I get too much Botox?
Is Botox the same as Botox Cosmetic?
What if I have a urinary tract infection?
What if I cannot empty my bladder fully?
Who makes Botox?
What are the common side effects of botulinum toxin A?
What drug class is botulinum toxin A?
What pregnancy or breastfeeding source fields are listed for botulinum toxin A?
Related Medications in Neuromuscular Blocker
Other drugs grouped near botulinum toxin A - same-class peers and common alternatives.
baclofen
Lioresal, Gablofen
Baclofen is a muscle relaxant.
Compare with botulinum toxin A →
carisoprodol
Soma
Carisoprodol is a muscle relaxant.
Compare with botulinum toxin A →
chlorzoxazone
Parafon Forte
Chlorzoxazone is a muscle relaxant.
Compare with botulinum toxin A →
cyclobenzaprine
Flexeril, Amrix
Cyclobenzaprine is a muscle relaxant.
Compare with botulinum toxin A →
dantrolene
Dantrium
Dantrolene is a muscle relaxant.
Compare with botulinum toxin A →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on botulinum toxin A
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for botulinum toxin A
The FDA label for botulinum toxin A (sold under brand names such as Botox) classifies it as a prescription-only medication in the Neuromuscular Blocker class. Botox can treat overactive bladder with symptoms like needing to go often, feeling a strong urge, and leaking urine. Official labeling lists 15 commonly reported side effects, including Urinary tract infection, Pain when urinating, Inability to fully empty the bladder.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. Interaction data is drawn directly from FDA-approved prescribing information. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: November 18, 2023
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages